SRT501 News
Most Popular SRT501 Story
Sirtris advances new therapies to combat aging
The New York Times examines the prospects of two drugs being developed by Sirtris to extend our life span. The therapies activate the sirtuin enzyme, mimicking a physiological reaction to famine that... Read more...
Latest Headlines
- July 22, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
